• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用邻近延伸分析(PEA)通过定量聚合酶链反应进行蛋白质组学分析。

Proteomics by qPCR Using the Proximity Extension Assay (PEA).

作者信息

Martínez-Moreno Julio Manuel, Llamas-Urbano Adrián, Barbarroja Nuria, Pérez-Sánchez Carlos

机构信息

Cobiomic Bioscience SL. EBT UCO/IMIBIC, Cordoba, Spain.

Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/Reina Sofia University Hospital/University of Cordoba (UCO), Córdoba, Spain.

出版信息

Methods Mol Biol. 2025;2929:129-142. doi: 10.1007/978-1-0716-4595-6_10.

DOI:10.1007/978-1-0716-4595-6_10
PMID:40601148
Abstract

The Proximity Extension Assay (PEA) is an innovative technology developed by Olink Proteomics that has revolutionized proteomics research. This method enables the simultaneous detection of hundreds of proteins using a minimal sample volume (1 microliter), combining the specificity of antibody-based immunoassays with the sensitivity of quantitative PCR (qPCR). The PEA process relies on the binding of two antibodies, each conjugated with unique DNA sequences, to a target protein. Upon proximity, these DNA sequences hybridize, forming a molecular barcode that is subsequently amplified by PCR, ensuring high specificity and minimizing cross-reactivity-an issue commonly encountered in multiplexed immunoassays. This chapter provides a detailed overview of the technical and methodological aspects of PEA, including the incubation, extension, amplification, and detection steps, as well as the quality control measures implemented in the Olink NPX Signature software for data analysis. This technology has been applied in more than 2000 peer-reviewed studies, demonstrating its potential for biomarker discovery in diagnostics, prognostics, and personalized medicine across various diseases. The integration of PEA into biomedical research continues to enhance the precision and reproducibility of proteomics studies.

摘要

邻近延伸分析(PEA)是由Olink蛋白质组学公司开发的一项创新技术,它彻底改变了蛋白质组学研究。该方法能够使用极少量样本(1微升)同时检测数百种蛋白质,将基于抗体的免疫分析的特异性与定量PCR(qPCR)的灵敏度相结合。PEA过程依赖于两种分别与独特DNA序列偶联的抗体与目标蛋白质的结合。当两种抗体靠近时,这些DNA序列杂交,形成一个分子条形码,随后通过PCR进行扩增,确保了高特异性并将多重免疫分析中常见的交叉反应降至最低。本章详细概述了PEA的技术和方法学方面,包括孵育、延伸、扩增和检测步骤,以及Olink NPX Signature软件中用于数据分析的质量控制措施。这项技术已应用于2000多项同行评审研究,证明了其在各种疾病的诊断、预后和个性化医疗中发现生物标志物的潜力。将PEA整合到生物医学研究中不断提高了蛋白质组学研究的准确性和可重复性。

相似文献

1
Proteomics by qPCR Using the Proximity Extension Assay (PEA).使用邻近延伸分析(PEA)通过定量聚合酶链反应进行蛋白质组学分析。
Methods Mol Biol. 2025;2929:129-142. doi: 10.1007/978-1-0716-4595-6_10.
2
Alternative Matrices for Protein Biomarker Analysis by qPCR Using Proximity Extension Assay (PEA).使用邻近延伸分析(PEA)通过qPCR进行蛋白质生物标志物分析的替代基质。
Methods Mol Biol. 2025;2929:171-193. doi: 10.1007/978-1-0716-4595-6_14.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
6
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
7
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
8
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

本文引用的文献

1
Decoding clinical and molecular pathways of liver dysfunction in Psoriatic Arthritis: Impact of cumulative methotrexate doses.解码银屑病关节炎中肝功能障碍的临床和分子途径:累积甲氨蝶呤剂量的影响。
Biomed Pharmacother. 2023 Dec;168:115779. doi: 10.1016/j.biopha.2023.115779. Epub 2023 Oct 30.
2
Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis.类风湿关节炎患者肝功能改变的临床特征及免疫机制。
Eur J Intern Med. 2023 Dec;118:49-58. doi: 10.1016/j.ejim.2023.08.002. Epub 2023 Aug 4.
3
Preclinical Characterization of Pharmacologic NAD Boosting as a Promising Therapeutic Approach in Rheumatoid Arthritis.
药理学提高NAD水平作为类风湿关节炎一种有前景的治疗方法的临床前特征研究
Arthritis Rheumatol. 2023 Oct;75(10):1749-1761. doi: 10.1002/art.42528. Epub 2023 Jul 28.
4
Characterization of the inflammatory proteome of synovial fluid from patients with psoriatic arthritis: Potential treatment targets.鉴定银屑病关节炎患者滑液中的炎症蛋白质组:潜在的治疗靶点。
Front Immunol. 2023 Mar 22;14:1133435. doi: 10.3389/fimmu.2023.1133435. eCollection 2023.
5
The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast.探索性银屑病关节炎队列的临床和分子心脏代谢特征与疾病活动相关,并受甲氨蝶呤和阿普米司特的差异调节。
J Intern Med. 2022 May;291(5):676-693. doi: 10.1111/joim.13447. Epub 2022 Mar 2.